ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0705

Mitochondrial Calcification-Induced Inflammation in Human Skeletal Muscle and Immune Cells

Bhargavi Duvvuri1, Lauren Pachman2, TING WANG1, Payton Hermanson1 and Christian Lood1, 1University of Washington, Seattle, WA, 2Northwestern's Feinberg School of Medicine. Ann and Robert H. Lurie Children's Hospital of Chicago; Stanley Manne Children's Research Institute of Chicago, Lake Forest, IL

Meeting: ACR Convergence 2021

Keywords: dermatomyositis, innate immunity, interferon

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Title: Muscle Biology, Myositis & Myopathies Poster (0683–0722)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Children with juvenile dermatomyositis (JDM) have decreased autophagy, as also confirmed by our RNA seq data in JDM muscle, which may contribute to accumulation of harmful agents. Consistent with that interpretation, our prior work demonstrated accumulation of calcified mitochondria in degenerated muscle fibers of JDM patients. In further mechanistic studies, we demonstrated mitochondrial reactive oxygen species (mtROS) as the main driver of mitochondrial calcification in human skeletal muscle cells. However, what remains to be explored is the effect of mitochondrial calcification on inflammation in calcifying skeletal muscle cells and in phagocytosing immune cells that may participate in clearance of calcified extruded mitochondria.

Methods: Mitochondrial calcification was induced in human skeletal muscle cells (RH30 cells) by addition of moderately high calcium-phosphate medium (Ca-P), and detected by fluorescent stain osteoimage. MtROS was measured using MitoSOX. Targeted metabolomics was performed on RH30 cells to identify potential pathways enriched upon mitochondrial calcification. Inflammation in RH30 cells was measured by RT-qPCR and ELISA. Mitochondrial DNA was measured using qPCR. Cardiolipin exposure was measured by flow cytometry. THP-1 monocytes were used to investigate the inflammatory potential of calcified mitochondria.

Results: Consistent with the role of calcium in mitochondrial metabolism, we found a significant increase in mtROS of calcified RH30 cells compared to untreated cells (p< 0.01). Pathway enrichment analysis on metabolites significantly downregulated in Ca-P treated cells revealed several mitochondrial-related pathways including mitochondrial respiration. In RH30 cells, upon mitochondrial calcification, there is a significant induction of interferon-stimulated gene expression and release of inflammatory cytokines including IL-1β (135 pg/mL vs. 75 pg/mL, p=0.0002). Further, cellular supernatants from calcified RH30 cells enriched in mtDNA could induce interferon responses in an interferon reporter cell line suggesting the extrusion of inflammatory mitochondria-derived components upon calcification of skeletal muscle cells. Consistent with these findings, investigation on isolated calcified mitochondria demonstrated a propensity of calcified mitochondria to release significant amounts mtDNA compared to non-calcified mitochondria (2,233,494 copies/mL vs. 581,655 copies /mL, p< 0.0001) and a trend for increased cardiolipin exposure (aCL MFI 18,500 vs. 10,271, p=0.07), suggesting destabilization of calcified mitochondria. Consistent with the proinflammatory nature of calcified mitochondria, THP-1 monocytes stimulated with calcified mitochondria but not non-calcified mitochondria secreted significant levels of IL-1β.

Conclusion: Mitochondrial calcification, as occurs in JDM, contributes to inflammation in skeletal muscle cells as well as in phagocytosing immune cells.


Disclosures: B. Duvvuri, None; L. Pachman, None; T. WANG, None; P. Hermanson, None; C. Lood, Exagen Diagnostic, 5, Eli Lilly, 5, Gilead, 5, Pfizer, 5, Horizon Diagnostic, 5.

To cite this abstract in AMA style:

Duvvuri B, Pachman L, WANG T, Hermanson P, Lood C. Mitochondrial Calcification-Induced Inflammation in Human Skeletal Muscle and Immune Cells [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/mitochondrial-calcification-induced-inflammation-in-human-skeletal-muscle-and-immune-cells/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mitochondrial-calcification-induced-inflammation-in-human-skeletal-muscle-and-immune-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology